KALA BIO (KALA) Earnings Analysis

KALA BIO (KALA) has no confirmed upcoming earnings date. Last quarter (2026-05-15) it beat with EPS -0.14 USD vs -8.5 USD est (+98.4%). It has beaten estimates in 4/5 recent quarters (80%). Trailing P/E -0.25.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does KALA next report earnings?

No confirmed upcoming earnings date is currently scheduled for KALA. This page updates as the calendar is published.

KALA earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-15-0.14 USD-8.5 USD+98.4%Beat
2026-04-150.0842 USD-16 USD+100.5%Beat
2025-11-19-1.07 USD-1.01 USD-5.9%Miss
2025-08-08-1.71 USD-1.82 USD+6%Beat
2025-03-31-1.74 USD-2.28 USD+23.7%Beat

Beat rate: 4/5 (80%) over reported quarters with consensus data.

KALA valuation and analyst view

Trailing P/E-0.25
Trailing EPS-2.41204 USD
Price / book0.56
Dividend yield0.00%
Market cap0.02B
Analyst consensusHold (4 buy / 6 hold / 1 sell)
Avg price target18.25 USD

Related research pages

Frequently asked questions

When is KALA BIO (KALA)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for KALA. This page updates as the calendar is published.

Did KALA beat earnings last quarter?

In its 2026-05-15 report, KALA posted EPS of -0.14 USD versus a -8.5 USD estimate — a beat of 98.4%.

What is KALA's earnings track record?

Over the last 5 reported quarters with consensus data, KALA beat estimates 4 times (80%).

What is KALA's current P/E ratio and EPS?

KALA trades at a trailing P/E of -0.25 on trailing EPS of -2.4120442670381155 USD.

What do analysts rate KALA?

Analyst consensus is "Hold" across 11 ratings (0 strong buy, 4 buy, 6 hold, 1 sell, 0 strong sell). Average 12-month price target: 18.25 USD.